Application of extract of cyclocarya paliurus in preparing medicine for treating or preventing diabetes cardiomyopathy
A technology of diabetic cardiomyopathy and its extract, which is applied in the application field of Cyclocarya paliurus extract in the preparation of medicines for treating diabetic cardiomyopathy, can solve the problems of no patents or literature reports, etc., and achieve the reduction of cardiomyocyte apoptosis and TNF -α, the effect of improving the structure and shape of cardiomyocytes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment example 1
[0023] Implementation case one Cyclocarya paliurus extract preparation
[0024] Weigh 35 kg of dried Cyclocarya paliurus, heat and reflux extract twice with 70% ethanol at 10 times the amount, for 2 hours each time, filter while hot, and combine the filtrates. Recover the solvent under reduced pressure until there is no alcohol smell, add water to disperse, and obtain the sample solution. Use D101 type macroporous resin to pack the column according to the diameter-to-height ratio of 1:4, the loading concentration (extract volume: solution volume) is 1:10, the volume ratio of extract volume to resin is 1:7, and the adsorption flow rate is 0.5BV / h, elution flow rate 2BV / h, wash 8BV to remove impurities, 30% ethanol to elute 10BV, 50% ethanol to elute 10BV, 75% ethanol to elute 10BV, collect 30%-75% ethanol eluate, recover solvent, vacuum After drying and weighing, 1.8 kg of the effective part of Cyclocarya paliurus was obtained.
[0025] The willow extract is applied to the p...
Embodiment example 2
[0029] Example 2 Determination of fasting blood sugar, total cholesterol and triglycerides
[0030] 48 6-week-old male db / db spontaneously diabetic mice were randomly divided into 5 groups: high, medium and low doses of total triterpenoids (ECL) of Cyclocarya paliurus were given ECL 80, 40, 20 mg·kg respectively. -1 d -1 Oral administration of the suspension; the model group was given the same dose of 0.9% normal saline 0.2mL. d -1 Gavage; the normal group did not intervene. Continuous intervention for 10 weeks. The fasting blood glucose of each group was detected before administration and at the 2nd, 4th, 6th, 8th, and 10th weekend after administration.
[0031] After the experimental administration, the mice were fasted for 12 hours, and blood was taken from the heart, 3500r·min -1Serum was collected by centrifugation for 10 min, and stored at 4°C for biochemical index detection. Fasting blood glucose was tested using a Roche blood glucose meter, and the content of tri...
Embodiment example 3
[0032] Implementation Case 3 Biochemical Index Detection
[0033] According to the kit instructions, the levels of LDH, CK, AST cardiac three enzymes, SOD, CAT, MDA, and GSH-PX were measured respectively, and cardiac troponin (cTnl) and inflammatory factors IFNγ, IL-1β, MCP-1, TNFα levels. Myocardial tissue was added with physiological saline at a mass volume ratio of 1:9, and after homogenization, 3 000r·min -1 After centrifugation for 10 min, the supernatant was taken to determine the levels of TGFβ1 and Collagen I according to the kit instructions.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com